J P Morgan1, R A Robins, H S Dua, P J Tighe. 1. The Larry Donoso Research Laboratory, Division of Ophthalmology and Visual Sciences, Eye Ear Nose and Throat Centre, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK. James.Morgan@nottingham.ac.uk
Abstract
BACKGROUND/AIMS: Effector T cell activation is particularly important in the initiation of autoimmune uveitis. This pilot study seeks to demonstrate activation of human peripheral effector T cells in response to the uveitis candidate autoantigen, retinal S antigen (SAg), using cytokine flow cytometry (CFC). METHODS: Peripheral blood mononuclear cell (PBMC) suspensions from uveitis patients and controls were stimulated with bovine SAg. Activation responses were detected by CFC. RESULTS: Electronic gating enabled analysis of CD69+, IFN-gamma+ CD4+ lymphocytes. An SAg specific response was detectable in four of 13 patients and four of eight controls. CONCLUSION: SAg specific, peripheral, effector T cell activation can be detected by CFC. Similar levels of responsiveness were seen in patient and control groups. More detailed cytokine profiling may demonstrate functional differences between the groups.
BACKGROUND/AIMS: Effector T cell activation is particularly important in the initiation of autoimmune uveitis. This pilot study seeks to demonstrate activation of human peripheral effector T cells in response to the uveitis candidate autoantigen, retinal S antigen (SAg), using cytokine flow cytometry (CFC). METHODS: Peripheral blood mononuclear cell (PBMC) suspensions from uveitispatients and controls were stimulated with bovineSAg. Activation responses were detected by CFC. RESULTS: Electronic gating enabled analysis of CD69+, IFN-gamma+ CD4+ lymphocytes. An SAg specific response was detectable in four of 13 patients and four of eight controls. CONCLUSION:SAg specific, peripheral, effector T cell activation can be detected by CFC. Similar levels of responsiveness were seen in patient and control groups. More detailed cytokine profiling may demonstrate functional differences between the groups.
Authors: V L Calder; B Shaer; M Muhaya; M Mclauchlan; R V Pearson; G Jolly; H M Towler; S Lightman Journal: Invest Ophthalmol Vis Sci Date: 1999-08 Impact factor: 4.799
Authors: G Doekes; R van der Gaag; A Rothova; Y van Kooyk; L Broersma; M J Zaal; G Dijkman; M E Fortuin; G S Baarsma; A Kijlstra Journal: Curr Eye Res Date: 1987-07 Impact factor: 2.424
Authors: R B Nussenblatt; A G Palestine; M El-Saied; S Meyers; Z Lando; C Mullenberg; L A Rozenszajn Journal: Curr Eye Res Date: 1984-02 Impact factor: 2.424
Authors: Abhijit Ray; Matthew A Williams; Stephanie M Meek; Randy C Bowen; Kenneth F Grossmann; Robert H I Andtbacka; Tawnya L Bowles; John R Hyngstrom; Sancy A Leachman; Douglas Grossman; Glen M Bowen; Sheri L Holmen; Matthew W VanBrocklin; Gita Suneja; Hung T Khong Journal: Oncotarget Date: 2016-09-27